This report by 2012 AVAC Advocacy Fellow Alice Kayongo-Mutebi describes successes and challenges in a year-long campaign to expand access to antiretroviral treatment for HIV positive people in Uganda. It includes sections on the history of Uganda’s AIDS response, achievements in the work of a Ugandan civil society coalition seeking to improve ART access. It describes challenges and makes recommendations for future work.
HIV/AIDS in Uganda: 30 Years On! – A case for treatment as prevention approach
We can use it if it’s made for us: Kenyan Sex workers perspectives and Voices on Microbicides and PrEP
This report gathers perceptions and concerns from female sex works in Kenya concerning access to microbicides and PrEP. It highlights the importance of engaging this key population in product research and development.
Too Little Too Slow: Results from from civil society monitoring of male circumcision for HIV prevention in Uganda
A jointly-authored report by Ugandan civil society groups taking stock of progress and challenges in Uganda’s voluntary medical male circumcision program as of 2012. Makes recommendations for future action, and highlights examples of best practices in the country.
FDA’s Advisory Committee Review of Daily Oral Truvada as PrEP to Reduce the Risk of HIV Infection: An advocate’s primer for public participation
This primer was developed to help advocates understand the mechanism of the US Food and Drug Administration’s external advisory committee. It was specifically developed in preparation for the US FDA review of Truvada for use as PrEP in 2012. It offers a guide to the workings of the external advisory committee (a set of outside experts who make recommendations) and ways for civil society to participate in the process.
An Action Agenda to End AIDS: Critical actions from 2012-2016 to begin to end the HIV/AIDS pandemic
Released at AIDS 2012, this report lays out a plan for beginning to end HIV/AIDS. It includes clear time-bound outcome targets, as well as the responsibilities of different stakeholders to achieve these targets.
Trials of Intermittent Dosing of Pre-Exposure Prophylaxis (PrEP): Summary from an AVAC think tank
Four-page summary of 2008 meeting on possibilities for intermittent PrEP research.
An Action Agenda to End AIDS: Quarterly monitoring report
The first update to An Action Agenda to End AIDS gives a status report on key actions and provides priority recommendations.
PrEP Financing in the US: Summary from an AVAC think tank
A six-page summary of an AVAC-convened think tank exploring possibilities of financing for PrEP in the United States.
An Action Agenda to End AIDS: Quarterly monitoring report
The second update to An Action Agenda to End AIDS gives a status report on key actions and provides priority recommendations.
An Action Agenda to End AIDS: Where are we in realizing the promise of beginning to end AIDS?
Issued in 2013, a year after An Action Agenda to End AIDS was first published, this document gives a status report on key actions and provides priority recommendations.